delirium for 3 days. She was lethargic upon admission and her blood pressure (BP) was recorded as 140/90 mm/Hg, her pulse rate (PR) as 75 beat/min and oral temperature as 38 °C. No localizing findings were observed in neurological examinations. Laboratory findings were as follows:
White Blood Cell (WBC) count: 7,000/mm3, Hemoglobin: 13 g/dl, Platelet count: 300000. Lumbar CSF, blood and urine cultures were found to be negative for infections. Brain Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) were also performed. MRI showed filling defects in the left transverse sinus, the jugular bulb and the internal jugular vein. Moreover, hyper-intense signal was observed in the left temporal lobe (T1 sequence) suggesting hemorrhagic venous infarction (Figure1). The obtained results were confirmed by Magnetic Resonance Venography (MRV) of the brain (Figure2). The patient underwent anticoagulation therapy using LMWH and she was? hydrated using physiologic solution. The patient's symptoms disappeared and she was then followed up regularly.
LEARNING POINTS
Cerebral Venous-Sinus Thrombosis (CVST) is a life threatening disease that accounts for only 0.5-1% of all strokes. CVTS occurs at all ages and its prevalence is estimated at about five per million of general population (1-3) . The clinical manifestations of CVST may be acute, sub-acute or chronic based on the location and extension of thrombosis including headache, vomiting, altered mental status and seizure (4). The major predisposing factors comprise pregnancy, oral contraceptive pill (OCP) use, coagulopathies, intracranial infections, dehydration, malignancy, and inflammatory bowel disease and etiology is unknown in about 30% of patients (3, 5) . Brain imaging plays a key role in diagnosing CVST owing to its nonspecific symptoms of the disease. CT angiogram and MR angiogram with venography are highly sensitive and specific in diagnosing CVST (5) . In the acute phase of CVST, heparin or LMWH are recommended followed by the oral anticoagulation for about 6-12 months (5) . The mortality rate of CVST is 6%-10%. Loss of consciousness is associated with higher mortality rates. CVST can therefore be associated with delirium in older adults and the treatment should not be postponed.
